−0.10CAD
−5.57 MCAD
6.48 KCAD
44.67 M
About MUSTGROW BIOLOGICS CORP
Sector
CEO
Corey J. Giasson
Headquarters
Saskatoon
Website
Founded
2014
ISIN
CA62822A1030
FIGI
BBG00PNSGFX0
MustGrow Biologics Corp. engages in the development and commercialization of natural biopesticide products from mustard seed. It offers preplant soil biofumigant, bioherbicide, and postharvest food preservation. The company was founded on December 2, 2014 and is headquartered in Saskatoon, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MGRO is 1.11 CAD — it has increased by 0.91% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange MUSTGROW BIOLOGICS CORP stocks are traded under the ticker MGRO.
MUSTGROW BIOLOGICS CORP is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
MGRO earnings for the last quarter are −0.02 CAD whereas the estimation was −0.02 CAD which accounts for 0% surprise. Estimated earnings for the next quarter are −0.02 CAD. See more details about MUSTGROW BIOLOGICS CORP earnings.
MUSTGROW BIOLOGICS CORP revenue for the last quarter amounts to 0 CAD despite the estimated figure of 0 CAD. In the next quarter revenue is expected to reach 1.00 K CAD.
Yes, you can track MUSTGROW BIOLOGICS CORP financials in yearly and quarterly reports right on TradingView.
Like other stocks, MGRO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MUSTGROW BIOLOGICS CORP stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MUSTGROW BIOLOGICS CORP EBITDA is −5.36 M CAD, and current EBITDA margin is −87.75 K%. See more stats in MUSTGROW BIOLOGICS CORP financial statements.